ERBB2 and breast cancer: Previous research has consistently shown a poorer prognosis for younger patients with ER-positive, ERBB2-negative breast cancer.16 Several population-based studies have highlighted young age as an independent risk factor associated with unfavorable outcomes specific to breast cancer.